Page last updated: 2024-11-04

temozolomide and Craniopharyngioma

temozolomide has been researched along with Craniopharyngioma in 3 studies

Craniopharyngioma: A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50)

Research Excerpts

ExcerptRelevanceReference
"Temozolomide is an alkylating chemotherapeutic agent used routinely in the management of high grade gliomas."1.37MGMT immunoexpression in adamantinomatous craniopharyngiomas. ( Altuntaş, Y; Aydın, Y; Karaman, O; Müslüman, AM; Ozderya, A; Ozkayalar, H; Oztürk, FY; Tanık, C; Zuhur, SS, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Raverot, G1
Ilie, MD1
Lasolle, H1
Amodru, V1
Trouillas, J1
Castinetti, F1
Brue, T1
Zairi, F1
Aboukais, R1
Maurage, CA1
Assaker, R1
Zuhur, SS1
Müslüman, AM1
Tanık, C1
Karaman, O1
Oztürk, FY1
Ozderya, A1
Ozkayalar, H1
Aydın, Y1
Altuntaş, Y1

Reviews

1 review available for temozolomide and Craniopharyngioma

ArticleYear
Aggressive pituitary tumours and pituitary carcinomas.
    Nature reviews. Endocrinology, 2021, Volume: 17, Issue:11

    Topics: Craniopharyngioma; Humans; Immunotherapy; Pituitary Neoplasms; Temozolomide; Tumor Microenvironment

2021

Other Studies

2 other studies available for temozolomide and Craniopharyngioma

ArticleYear
Glioblastoma occurring after the surgical resection of a craniopharyngioma.
    British journal of neurosurgery, 2014, Volume: 28, Issue:2

    Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Clinical Protocols; Cra

2014
MGMT immunoexpression in adamantinomatous craniopharyngiomas.
    Pituitary, 2011, Volume: 14, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Biomarkers, Pharmacological; Biomarkers, Tumor

2011